Due Diligence for critical investment decisions

The consequences of decisions made when selecting a new drug delivery device can last 10 to 15 years, plus. In this context it is critical to ensure that due diligence is carried out carefully and effectively.

An effective device selection process is analogous to developing a great new product; it requires similar skills and experience. To cut through the sales promises, the selection process must be designed and carried out with an in-depth and qualified understanding of the device technology and its development process. Our track record in developing award-winning devices that have achieved global success means that we know exactly what to look for, and the right questions to ask, when helping our clients to select a device.

DCA regularly supports the review and selection of drug delivery devices for major pharmaceutical clients, providing an independent and expert view that leverages our extensive experience across a wide range of device types and development activities, from new product strategy to industrialisation and lifecycle support.

Our multidisciplinary team of experts has the capability to provide in-depth understanding and insights into the device usability, design, engineering, evaluation, software, electronics, manufacture and assembly. In all of these skill areas, we have the specialist knowledge that is critical for successful device development, making us the perfect partner for due diligence.